PR
August 29, 2018

Talis Bio awarded $4.4M by CARB-X

To fund development of rapid point-of-care diagnostic tests for pathogen identification and antibiotic susceptibility https://www.prnewswire.com/news-releases/talis-biomedical-corporation-awarded-4-4m-by-carb-x-300646438.html…